Intco Medical Technology Co., Ltd. Class A 300677
SZSE · China · Health Technology
CNY 50.96+1.78 (+3.62%)
Market closed· · CNY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · CNY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
INTCO Medical ("the Company", 300677.SZ), a leading global manufacturer of disposable gloves, reported revenue of RMB 6.91 billion (approx. US$1.03 billion) for the six months ended June 30, 2026, up 40.61% from a year earlier. Net profit attributable to shareholders rose 17.86% to RMB 837.3 million (approx. US$124.6 million). Adjusted net profit attributable to shareholders, excluding nonrecurring gains and losses, climbed 165.00% to RMB 1.06 billion (approx. US$157.7 million).
INTCO Medical ("the Company"), a leading global manufacturer of disposable gloves, has been included in S&P Global's Sustainability Yearbook (China Edition) 2025 and recognized as an Industry Mover for its ESG progress, reflecting the Company's continued progress in environmental, social and governance (ESG) performance.
INTCO Medical ("the Company"), a leading global manufacturer of disposable gloves, has released its 2025 Environmental, Social and Governance (ESG) Report, outlining progress in emissions reduction, clean energy adoption, product innovation, quality management, corporate governance and social responsibility as the Company advances its long-term sustainability strategy.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.